VEGFA and cancer: Additionally, this activation is correlated with heightened malignancy since it alters the transcription implicated in proliferation (cyclin D1 and Cellular Myelocytomatosis Oncogene), angiogenesis (vascular endothelial growth factor), and pro-inflammatory cytokines associated with cancer progression (Interleukin-1 and IL-6) (Figure 4).